Clinical Trials Logo

Clinical Trial Summary

Consultation time in busy respiratory clinics is inevitably limited and attendance is often disruptive to patients' lives; involves time, expense, travel, and waiting; and can have effects upon occupation. Published work suggests that patient satisfaction with telephone consultations is high and this subject has recently been extensively reviewed by one of the study investigators. In respiratory medicine there is United States (US) data to suggest that the regular telephoning of adolescents with asthma by a specialist nurse can reduce unscheduled use of health service resources. In the United Kingdom (UK), a randomised, controlled trial in primary care has shown that, compared to face to face consultations, use of the telephone can enable greater numbers of patients with asthma to be reviewed. Another of the study investigators has undertaken a feasibility study in a general respiratory clinic and has shown the concept of alternating face to face consultation with telephone consultation to be acceptable to over 80% of patients. Over one third were assessed to be suitable in that they did not need to attend the clinic for either physical examination or for investigations. It is therefore proposed to evaluate the feasibility, acceptability, time savings and safety of the use of telephone consultation in 3 respiratory clinics in the Department of Respiratory Medicine at Charing Cross Hospital.


Clinical Trial Description

Patients to be included in the study would be those attending 3 respiratory clinics. The patients would be asked if they were willing to have a telephone consultation instead of their next face to face consultation and this would be explained to them. "Many patients attending a Chest Clinic need to do so only once. For others their condition merits regular review. Most of these people need to come to the clinic because they need chest x-rays, blood tests or breathing tests. However some patients return for review of their condition without needing any specialist investigations. We are keen to assess what proportion of our patients would be suitable for telephone consultations rather than face to face consultations and to see what advantages there might be for both patients and doctors. We are therefore interested to assess the use of telephone consultation where suitable and would like to know if you would be willing to try telephone consultation for your next appointment. In the case of telephone consultation you would be offered a day, date and time at which you would be phoned. Your consultant, would then ring you him or herself within half an hour of the appointed time {and procedurally it has been agreed by the trial participants that if, for any reason, during the trial period they are delayed with the previous patient they will excuse themselves to telephone the following patient to say that they have been delayed and they will ring them back within 15 minutes, for example} and with your clinical notes in front of them he or she would enquire in the usual way regarding how you feel, ask about your symptoms and give advice regarding any concerns you may have or advise regarding changes in treatment. You would subsequently receive a copy of the letter summarising the telephone consultation when it was sent to your general practitioner. If the telephone consultation suggested that you needed to be seen in the clinic you would be offered an appointment within two weeks of the telephone call." Demographic details and disease diagnosis would be recorded, for those not deemed suitable or for those not wishing to take part and they would continue to attend traditional face to face consultations. Those having a telephone consultation would subsequently revert to traditional consultation pending results of the trial. Frequency of planned consultation would be as per the consultant's usual practice. Procedurally, it was agreed that for those patients agreeing to have their next consultation by telephone, the doctor would check the phone number which they wished for the investigators to use and this would be inserted in the notes at the end of the previous consultation with a large black box around it, so that it could easily be spotted at the time of the telephone consultation. For all patients the following observations would be made: length of the telephone consultation, fail to be available when telephoned rate, and length of each face to face consultation. For each face to face consultation the following information would be recorded: the time they left home; time of arrival at hospital, time spent waiting for consultation, expense of attendance, both travel costs but also any indirect costs such as babysitting charges and loss of earnings. For each telephone consultation the number of patients having to be reviewed within the next 2 weeks of the telephone consultation would be recorded, whether such expedited follow up was at the patient's or the doctor's behest. After both the telephone consultation and their subsequent face to face consultation the patients would be asked to complete the post consultation patient satisfaction questionnaire, the MISS 21 questionnaire and the Howie Enablement Instrument. Patients would be posted these scales by first class post on the day of a telephone consultation and handed them for completion after a face to face consultation and on each occasion they would be given a stamped addressed envelope in which to return the completed scores. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00129701
Study type Interventional
Source Imperial College London
Contact
Status Completed
Phase N/A
Start date November 2003
Completion date January 2006

See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device